AMNEAL PHARMACEUTICALS, INC Total Assets 2009-2018 | AMRX

AMNEAL PHARMACEUTICALS, INC total assets from 2009 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
AMNEAL PHARMACEUTICALS, INC Annual Total Assets
(Millions of US $)
2018 $4,353
2017 $1,342
2016 $1,823
2015 $1,922
2014 $1,079
2013 $997
2012 $864
2011 $794
2010 $693
2009 $661
2008 $514
2007 $516
2006 $0
AMNEAL PHARMACEUTICALS, INC Quarterly Total Assets
(Millions of US $)
Q4 2018 $4,353
Q3 2018 $4,582
Q2 2018 $4,545
Q1 2018 $1,221
Q4 2017 $1,342
Q3 2017 $1,649
Q2 2017 $1,701
Q1 2017 $1,696
Q4 2016 $1,823
Q3 2016 $2,120
Q2 2016 $1,850
Q1 2016 $1,886
Q4 2015 $1,922
Q3 2015 $1,996
Q2 2015 $2,032
Q1 2015 $1,782
Q4 2014 $1,079
Q3 2014 $1,092
Q2 2014 $1,059
Q1 2014 $982
Q4 2013 $997
Q3 2013 $1,015
Q2 2013 $1,010
Q1 2013 $1,009
Q4 2012 $864
Q3 2012 $901
Q2 2012 $958
Q1 2012 $903
Q4 2011 $794
Q3 2011 $752
Q2 2011 $744
Q1 2011 $718
Q4 2010 $693
Q3 2010 $705
Q2 2010 $848
Q1 2010 $845
Q4 2009 $661
Q3 2009 $530
Q2 2009 $516
Q1 2009 $512
Q4 2008 $514
Q3 2008 $0
Q2 2008 $0
Q1 2008 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.841B $1.861B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.866B 32.47
Takeda Pharmaceutical (TAK) Japan $28.763B 10.64
Grifols (GRFS) Spain $13.022B 15.92
Ionis Pharmaceuticals (IONS) United States $10.380B 32.19
Sage Therapeutics (SAGE) United States $7.864B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.405B 10.60
Neurocrine Biosciences (NBIX) United States $7.366B 474.77
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.505B 8.78
Tilray (TLRY) United States $4.865B 0.00
United Therapeutics (UTHR) United States $4.561B 7.76
Taro Pharmaceutical Industries (TARO) Israel $4.165B 13.41
FibroGen (FGEN) United States $4.101B 0.00
Portola Pharmaceuticals (PTLA) United States $2.408B 0.00
PTC Therapeutics (PTCT) United States $2.130B 0.00
USANA Health Sciences (USNA) United States $1.922B 16.12
Heron Therapeutics (HRTX) United States $1.884B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.856B 0.00
Xencor (XNCR) United States $1.836B 0.00
Aerie Pharmaceuticals (AERI) United States $1.814B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.734B 21.60
Madrigal Pharmaceuticals (MDGL) United States $1.685B 0.00
Endo (ENDP) Ireland $1.656B 2.55
Pacira Pharmaceuticals (PCRX) United States $1.617B 139.82
Zogenix (ZGNX) United States $1.586B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.385B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.171B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.079B 0.00
TherapeuticsMD (TXMD) United States $1.008B 0.00
Radius Health (RDUS) United States $0.995B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.898B 0.00
Akebia Therapeutics (AKBA) United States $0.781B 0.00
CannTrust Holdings (CTST) Canada $0.767B 0.00
ChemoCentryx (CCXI) United States $0.738B 0.00
ArQule (ARQL) United States $0.713B 0.00
Dermira (DERM) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.604B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
Forty Seven (FTSV) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
GlycoMimetics (GLYC) United States $0.562B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.555B 0.00
Collegium Pharmaceutical (COLL) United States $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 24.03
TCR2 THERAPTCS (TCRR) United States $0.450B 0.00
KalVista Pharmaceuticals (KALV) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.437B 0.00
OptiNose (OPTN) United States $0.418B 0.00
Flexion Therapeutics (FLXN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.393B 0.00
Aptorum Group (APM) China $0.389B 0.00
Mast Therapeutics (SVRA) United States $0.383B 0.00
ImmunoGen (IMGN) United States $0.375B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Karyopharm Therapeutics (KPTI) United States $0.303B 0.00
Minerva Neurosciences (NERV) United States $0.287B 0.00
Harpoon Therapy (HARP) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.283B 2.63
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.280B 10.38
AcelRx Pharmaceuticals (ACRX) United States $0.276B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Aclaris Therapeutics (ACRS) United States $0.258B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.246B 0.00
Dova Pharmaceuticals (DOVA) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Concert Pharmaceuticals (CNCE) United States $0.227B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Ardelyx (ARDX) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.206B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.204B 0.00
Affimed (AFMD) Germany $0.203B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 190.00
Majesco Entertainment (PTE) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
ElectroCore (ECOR) United States $0.176B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.169B 0.00
Ocular Therapeutix (OCUL) United States $0.165B 0.00
IMV INC (IMV) Canada $0.165B 0.00
Tyme Technologies (TYME) United States $0.163B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
MediWound (MDWD) Israel $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
China SXT Pharmaceuticals (SXTC) China $0.120B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Neos Therapeutics (NEOS) United States $0.115B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Oasmia Pharmaceutical AB (OASM) Sweden $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
DURECT (DRRX) United States $0.092B 0.00
Zafgen (ZFGN) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.041B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 3.62
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Shineco (TYHT) China $0.027B 4.58
PharmAthene (ALT) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.76
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Achaogen (AKAO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00